Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of PNEUMOSIL in healthy infants in The Gambia
PACTR201907754270299Phase 3Completed
- Sponsor
- PATH
- Start
- Jul 2019
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of SIILPCV10 in pneumococcal disease (3 arms), sponsored by PATH. Started Jul 2019; status: completed.
02
Drugs
SIILPCV10
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on PACTR201907754270299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201907754270299.